The Effects of Ozurdex® (Dexamethasone Intravitreal Implant) on Experimental Proliferative Vitreoretinopathy

Publisher： Karger

E-ISSN： 1423-0267|233|3-4|198-203

ISSN： 0030-3755

Source： Ophthalmologica, Vol.233, Iss.3-4, 2015-02, pp. : 198-203

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreal Dexamethasone Implant (Ozurdex) in Coats' Disease

By  

Case Reports in Ophthalmology, Vol. 4, Iss. 3, 2013-09 ,pp. : 122-128

Karger

Access to resources Recommend Favorite

Rhegmatogenous Retinal Detachment with a High Risk of Proliferative Vitreoretinopathy Treated with Episcleral Surgery and an Intravitreal Dexamethasone 0.7-mg Implant

By  

Case Reports in Ophthalmology, Vol. 4, Iss. 1, 2013-04 ,pp. : 79-83

Karger

Access to resources Recommend Favorite

Repeated Intravitreal Dexamethasone Implant (Ozurdex®) for Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 229, Iss. 1, 2012-09 ,pp. : 21-25

Karger

Access to resources Recommend Favorite

Experimental Model for Proliferative Vitreoretinopathy by Intravitreal Dispase: Limited by Zonulolysis and Cataract

By  

Ophthalmologica, Vol. 220, Iss. 4, 2006-06 ,pp. : 211-216

Karger

Access to resources Recommend Favorite

Exploring the Morphological and Functional Retinal Changes after Dexamethasone Intravitreal Implant (Ozurdex®) in Macular Edema due to Retinal Vein Occlusion

By  

Ophthalmic Research, Vol. 51, Iss. 3, 2014-03 ,pp. : 153-160

Karger

Access to resources Recommend Favorite